Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 09/19/2025 | CALL | $767.00 | 1,300 | +1,300 | |
| 09/19/2025 | PUT | $767.00 | 1,300 | +1,300 | |
| 10/03/2025 | CALL | $767.00 | 1,300 | +1,300 | |
| 10/03/2025 | PUT | $767.00 | 1,300 | +1,300 | |
| 10/17/2025 | PUT | $790.00 | 1,016 | +955 | +1,565.57% |
| 10/17/2025 | CALL | $760.00 | 770 | +770 | |
| 12/19/2025 | PUT | $630.00 | 1,039 | -546 | -34.45% |
| 09/19/2025 | PUT | $780.00 | 1,260 | -752 | -37.38% |
| 09/19/2025 | CALL | $660.00 | 0 | -770 | -100.00% |
| 09/19/2025 | PUT | $660.00 | 0 | -770 | -100.00% |
| 09/19/2025 | CALL | $650.00 | 2,000 | -1,200 | -37.50% |
| 09/19/2025 | PUT | $650.00 | 2,000 | -1,200 | -37.50% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.74% | 26M | 11.45B |
| Vanguard 500 Index Fund | 1.92% | 18.23M | 8.03B |
| Vanguard/Primecap Fund | 1.56% | 14.85M | 6.54B |
| Fidelity 500 Index Fund | 0.91% | 8.65M | 3.81B |
| SPDR S&P 500 ETF Trust | 0.90% | 8.54M | 3.76B |
| Vanguard Specialized-Health Care Fund | 0.80% | 7.64M | 3.37B |
| iShares Core S&P 500 ETF | 0.74% | 7.04M | 3.1B |
| Washington Mutual Investors Fund | 0.73% | 6.95M | 3.06B |
| Growth Fund Of America Inc | 0.71% | 6.7M | 2.95B |
| Select Sector SPDR Fund-Health Care | 0.67% | 6.41M | 2.82B |
Eli Lilly Stock Outlook: Fast-Track Oral GLP-1 Review Meets Long-Term Catalysts
09/18 03:35 pm
Investing.com
Read moreJapan Auto-Injectors for Glp-1 Receptor Agonists Market Outlook Report 2025-2038: Convenience and Compliance Boost Adoption As At-home Delivery Methods is Growing
09/18 10:54 am
GlobeNewswire Inc.
Read moreWhy Novo Nordisk Stock Popped Today
09/17 11:02 am
The Motley Fool
Read moreGSK To Pour $30 Billion Into US R&D, Manufacturing Over Five Years
09/17 10:06 am
Benzinga
Read moreCould This Eli Lilly Oral Pill Be Key To Significant Weight Loss?
09/17 09:00 am
Benzinga
Read moreWhy Eli Lilly Stock Was a Winner Today
09/16 06:15 pm
The Motley Fool
Read moreFDA Flags Eli Lilly's Weight-Loss Drug Video For Misleading Claims
09/16 02:10 pm
Benzinga
Read moreEli Lilly To Invest $5 Billion In New Virginia Manufacturing Facility To Support Cancer Drugs Manufacturing
09/16 12:22 pm
Benzinga
Read moreWegovy's Next Step: Novo Nordisk Eyes Approval for Higher-Dose Treatment
09/16 10:21 am
Benzinga
Read moreHere Is My Top Stock Pick Among the Weight Loss Industry Leaders
09/16 03:15 am
The Motley Fool
Read moreAstraZeneca Puts Cambridge Expansion On Ice Adding Pressure On Starmer Ahead Of Trump Visit
09/15 11:39 am
Benzinga
Read more1 Stock That Should Be in Every Investor's Portfolio
09/15 06:15 am
The Motley Fool
Read moreThis Under-the-Radar Healthcare Stock Could Soar in 2026
09/12 08:15 am
The Motley Fool
Read more2 Monster Stocks to Hold for the Next 5 Years
09/11 04:20 am
The Motley Fool
Read moreWegovy And Zepbound Cost Effective But They Could Break Drug Budgets
09/10 09:23 am
Benzinga
Read moreImmuneering to Announce Updated Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on September 25
09/10 07:00 am
GlobeNewswire Inc.
Read moreEli Lilly's Jaypirca Surpasses Chemoimmunotherapy For Untreated Blood Cancer Patients
09/08 01:00 pm
Benzinga
Read moreProgesterone Market Size Drives at 12.74% CAGR to Hit USD 5.05 Billion by 2034
09/08 11:00 am
GlobeNewswire Inc.
Read moreFDA Tightens Grip On Safe Weight Loss Drugs, WHO Adds Them To Essential Medicines List
09/07 02:00 pm
Benzinga
Read moreThink It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time.
09/07 11:14 am
The Motley Fool
Read more2 S&P 500 Dividend Stocks That Could Climb More Than 20% According to Wall Street Analysts
09/05 04:29 am
The Motley Fool
Read moreDown 34%, Should You Buy the Dip on Viking Therapeutics?
09/05 04:10 am
The Motley Fool
Read moreMonoclonal Antibodies Therapeutics Market Size Projected to Reach USD 1,057.91 Billion by 2034
09/04 11:00 am
GlobeNewswire Inc.
Read moreWhere Will Eli Lilly Be in 3 Years?
09/04 04:25 am
The Motley Fool
Read moreAC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway
09/04 03:45 am
GlobeNewswire Inc.
Read moreIs Novo Nordisk Stock a Buy Now?
09/03 05:07 am
The Motley Fool
Read moreStomach Cancer Treatment Market Review 2020-2024 and Forecast 2025-2030 - Novel Therapies, Increasing Demand for Affordable Treatments, and Favorable Reimbursement Scenario Position the Market for Strong Growth
09/03 04:49 am
GlobeNewswire Inc.
Read moreMaze Therapeutics Appoints Misbah Tahir as Chief Financial Officer
09/02 07:00 am
GlobeNewswire Inc.
Read moreFDA Tightens Safety Guidelines For Biogen Leqembi Alzheimer's Therapy
08/29 10:09 am
Benzinga
Read moreSGLT2 Inhibitors Market to Hit USD 29.73 Billion by 2032, Driven by Expanding Diabetes Management and Cardiovascular Benefits – SNS Insider
08/29 09:00 am
GlobeNewswire Inc.
Read more2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts
08/29 04:26 am
The Motley Fool
Read moreNVIDIA Announces Upcoming Event for Financial Community
08/28 05:00 pm
GlobeNewswire Inc.
Read more2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
08/28 03:26 am
The Motley Fool
Read moreHuman Growth Hormone Market to Hit USD 18.25 Billion by 2032, Driven by Expanding Therapeutic Applications and Biotech Advances – SNS Insider
08/27 10:00 am
GlobeNewswire Inc.
Read moreBinge Eating Disorders Global Market Research Report 2025-2035 Featuring Eli Lilly, Amneal, Takeda, Tryp Therapeutics, Tonix, Sumitomo, VIVUS, Novartis, and Pfize
08/27 08:00 am
GlobeNewswire Inc.
Read moreWhy Novo Nordisk Stock Tumbled on Tuesday
08/26 06:23 pm
The Motley Fool
Read moreRussell 2000 Hits 9-Month Highs, Bitcoin Drops Below $110,000: What's Moving Markets Tuesday?
08/26 02:12 pm
Benzinga
Read moreAs the Market Rotates, This Healthcare ETF Is Leading the Way
08/26 10:07 am
Investing.com
Read moreIndustry Leaders Transform Enterprise Data Centers for the AI Era With NVIDIA RTX PRO Servers
08/26 09:00 am
GlobeNewswire Inc.
Read moreViking Therapeutics: What's Next?
08/26 06:15 am
The Motley Fool
Read moreIncyclix Bio Secures $11.25 Million Series B Extension to Advance the Phase 1/2 Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors
08/25 07:00 am
GlobeNewswire Inc.
Read moreThe Best Stocks to Invest $50,000 in Right Now
08/24 04:32 am
The Motley Fool
Read moreIf I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
08/23 06:05 pm
The Motley Fool
Read moreAnal Cancer Market Size to Reach USD 2.08 Billion by 2032, Fueled by Rising HPV-Linked Cases and Advancements in Targeted Therapies – SNS Insider
08/22 10:00 am
GlobeNewswire Inc.
Read moreEli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried?
08/22 09:30 am
The Motley Fool
Read moreEli Lilly and Company Investors: Company Investigated by the Portnoy Law Firm
08/21 05:25 pm
GlobeNewswire Inc.
Read moreHealthcare ETF Discount Highlights Value Ahead of Ozempic Growth Cycle
08/21 03:46 pm
Investing.com
Read moreIs Beaten-Down Viking Therapeutics Stock a Buy on the Dip?
08/21 05:24 am
The Motley Fool
Read more